Related Experiment Videos
An androgen-associated hepatic adenoma in a trans-sexual
The British Journal of Surgery
|December 1, 1978
Abstract:
A case is reported of an hepatic adenoma developing in a patient who had been taking testosterone for 3 years. There appears to be an association between various steroid preparations and hepatic neoplasia. Reports of such cases with all relevant data will allow a balanced assessment of the problem to be made.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The diagnosis and prognosis of molar pregnancy: The experience of the National Referral Centre in London.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
Glucose effects on the peritoneum: what can we learn from rodent models?
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2012
Dehiscence, Infection, Seroma, Haematoma (DISH): Development and Validation of a New Classification of Surgical Site Outcomes.
The British journal of surgery·2026
Macrophage-mediated inflammation and microcalcification are associated with abdominal aortic aneurysm progression and clinical events.
The British journal of surgery·2026
Aortic dissection incidence, management, and outcomes: national population-based study.
The British journal of surgery·2026
Effects of Acute Low- and Moderate-Dose Alcohol on Chronic Disease-Related Biomarkers in Healthy Light and Heavy Drinkers.
Alcohol, clinical & experimental research·2026
Luciferase-induced immune activation prevents orthotopic K7M2luc osteosarcoma establishment in BALB/c mice.
Radiology and oncology·2026
CD248/Endosialin regulates synovial fibroblast state to control coupling of inflammation and bone damage in murine models of immune-mediated inflammatory arthritis and ageing.
Arthritis & rheumatology (Hoboken, N.J.)·2026
New Observations on a Low-Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour Type.
Neuropathology and applied neurobiology·2026